Fiera Capital Corp Acquires 30,065 Shares of Veeva Systems Inc. (NYSE:VEEV)

Fiera Capital Corp increased its holdings in shares of Veeva Systems Inc. (NYSE:VEEV - Free Report) by 11.6% in the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission. The fund owned 289,272 shares of the technology company's stock after purchasing an additional 30,065 shares during the quarter. Fiera Capital Corp owned approximately 0.18% of Veeva Systems worth $55,691,000 as of its most recent SEC filing.

Other hedge funds have also added to or reduced their stakes in the company. Facet Wealth Inc. grew its stake in shares of Veeva Systems by 3.2% in the fourth quarter. Facet Wealth Inc. now owns 1,542 shares of the technology company's stock valued at $323,000 after buying an additional 48 shares in the last quarter. NewEdge Wealth LLC increased its stake in shares of Veeva Systems by 0.6% during the 3rd quarter. NewEdge Wealth LLC now owns 10,059 shares of the technology company's stock worth $2,047,000 after purchasing an additional 60 shares during the last quarter. Yousif Capital Management LLC increased its stake in shares of Veeva Systems by 3.5% during the 4th quarter. Yousif Capital Management LLC now owns 1,777 shares of the technology company's stock worth $342,000 after purchasing an additional 60 shares during the last quarter. Personal CFO Solutions LLC raised its holdings in shares of Veeva Systems by 5.9% in the 3rd quarter. Personal CFO Solutions LLC now owns 1,091 shares of the technology company's stock valued at $222,000 after purchasing an additional 61 shares during the period. Finally, Sequoia Financial Advisors LLC grew its holdings in Veeva Systems by 3.4% during the third quarter. Sequoia Financial Advisors LLC now owns 1,940 shares of the technology company's stock worth $395,000 after purchasing an additional 63 shares during the period. Institutional investors own 88.20% of the company's stock.

Wall Street Analyst Weigh In

Several brokerages have recently commented on VEEV. Robert W. Baird lifted their target price on Veeva Systems from $245.00 to $251.00 and gave the stock an "outperform" rating in a research note on Friday, March 1st. Oppenheimer restated an "outperform" rating and set a $225.00 target price on shares of Veeva Systems in a research note on Thursday, February 22nd. Royal Bank of Canada reiterated an "outperform" rating and issued a $250.00 price target on shares of Veeva Systems in a research note on Wednesday, March 27th. JPMorgan Chase & Co. upped their target price on Veeva Systems from $183.00 to $222.00 and gave the company a "neutral" rating in a research report on Wednesday, March 13th. Finally, Jefferies Financial Group lifted their target price on Veeva Systems from $225.00 to $270.00 and gave the stock a "buy" rating in a report on Monday, March 4th. One analyst has rated the stock with a sell rating, five have given a hold rating and fifteen have assigned a buy rating to the company. According to data from MarketBeat.com, the stock currently has a consensus rating of "Moderate Buy" and an average target price of $234.90.

Insider Transactions at Veeva Systems

In related news, Director Timothy S. Cabral sold 15,000 shares of the firm's stock in a transaction that occurred on Thursday, March 7th. The stock was sold at an average price of $226.04, for a total transaction of $3,390,600.00. Following the completion of the sale, the director now owns 23,391 shares of the company's stock, valued at $5,287,301.64. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. In other Veeva Systems news, SVP Jonathan Faddis sold 3,598 shares of the company's stock in a transaction on Monday, April 15th. The shares were sold at an average price of $207.42, for a total transaction of $746,297.16. Following the transaction, the senior vice president now owns 10,668 shares in the company, valued at $2,212,756.56. The transaction was disclosed in a filing with the SEC, which is accessible through this link. Also, Director Timothy S. Cabral sold 15,000 shares of the firm's stock in a transaction dated Thursday, March 7th. The shares were sold at an average price of $226.04, for a total transaction of $3,390,600.00. Following the completion of the transaction, the director now directly owns 23,391 shares in the company, valued at approximately $5,287,301.64. The disclosure for this sale can be found here. In the last 90 days, insiders have sold 21,989 shares of company stock worth $4,818,013. Company insiders own 10.50% of the company's stock.

Veeva Systems Price Performance

Shares of NYSE VEEV traded down $1.73 during mid-day trading on Thursday, hitting $209.65. 926,329 shares of the stock traded hands, compared to its average volume of 924,692. The company has a market cap of $33.82 billion, a PE ratio of 65.11, a price-to-earnings-growth ratio of 2.06 and a beta of 0.76. Veeva Systems Inc. has a twelve month low of $160.21 and a twelve month high of $236.90. The firm has a 50 day simple moving average of $214.29 and a two-hundred day simple moving average of $202.53.

Veeva Systems (NYSE:VEEV - Get Free Report) last issued its quarterly earnings results on Thursday, February 29th. The technology company reported $0.92 EPS for the quarter, topping analysts' consensus estimates of $0.81 by $0.11. Veeva Systems had a net margin of 22.24% and a return on equity of 11.26%. The company had revenue of $630.62 million for the quarter, compared to analyst estimates of $620.75 million. On average, equities research analysts anticipate that Veeva Systems Inc. will post 4.11 earnings per share for the current fiscal year.

Veeva Systems Company Profile

Veeva Systems Inc provides cloud-based software for the life sciences industry. It offers Veeva Commercial Cloud, a suite of software and analytics solutions, such as Veeva customer relationship management (CRM) that enable customer-facing employees at pharmaceutical and biotechnology companies; Veeva Vault PromoMats, an end-to-end content and digital asset management solution; Veeva Vault Medical that provides source of medical content across multiple channels and geographies; Veeva Crossix, an analytics platform for pharmaceutical brands; Veeva OpenData, a customer reference data solution; Veeva Link, a data application that allows link to generate real-time intelligence; and Veeva Compass includes de-identified and longitudinal patient data for the United States.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.